Filing Details
- Accession Number:
- 0001140361-14-039584
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-30 19:27:30
- Reporting Period:
- 2014-10-28
- Filing Date:
- 2014-10-30
- Accepted Time:
- 2014-10-30 19:27:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1302573 | Oncomed Pharmaceuticals Inc | OMED | Pharmaceutical Preparations (2834) | 383572512 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1309702 | J Paul Hastings | C/O Oncomed Pharmaceuticals, Inc. 800 Chesapeake Drive Redwood City CA 94063 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-28 | 8,384 | $1.43 | 31,615 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-28 | 8,384 | $22.08 | 23,231 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-10-29 | 8,385 | $1.43 | 31,616 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-29 | 8,385 | $21.90 | 23,231 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-10-28 | 8,384 | $0.00 | 8,384 | $1.43 |
| Common Stock | Stock Option (RIght to Buy) | Disposition | 2014-10-29 | 8,385 | $0.00 | 8,385 | $1.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 51,123 | 2017-01-11 | No | 4 | M | Direct | |
| 42,738 | 2017-01-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 324,840 | Indirect | See Footnote |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 22, 2014.
- Includes 22,500 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit.
- Includes 731 shares acquired under the Issuer's Employee Stock Purchase Plan on August 29, 2014
- This transaction was executed in multiple trades in prices ranging from $21.79 to $22.37, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- This transaction was executed in multiple trades in prices ranging from $21.31 to $22.15, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The shares are held by Paul J. Hastings & Steve N. De Jong, Trustors and/or TTEES, The Hastings-De Jong Lv Tr DTD May 1, 2012.
- The option is fully vested and exercisable, subject to an annual limitation of 175,438 shares that can be issued to a single grantee upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan.
Billionaire Hedge Funds
